RecruitingNCT07416773

Anesthesia Technique and Postoperative Sleep Quality After Septoplasty

Evaluation of the Relationship Between Anesthesia Type and Postoperative Sleep Quality in Patients Undergoing Septoplasty: A Prospective Observational Study

Sponsor

Sevim Şenol Karataş

Enrollment

72 participants

Start Date

Nov 15, 2025

Study Type

OBSERVATIONAL

Conditions

Anesthesia Techniques Postoperative Sleep Quality Septal Deviation

Summary

This prospective observational study aims to evaluate the relationship between anesthesia type and postoperative sleep quality in adult patients undergoing septoplasty. Patients will receive either total intravenous anesthesia or inhalational anesthesia as part of routine clinical care, without any intervention or modification to standard practice. Postoperative sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire on postoperative days 7 and 15 through structured telephone interviews. Secondary outcomes include postoperative pain intensity, opioid consumption, and postoperative nausea and vomiting. The study seeks to provide real-world evidence on the association between anesthetic approach and posto

Eligibility

Min Age: 18 Years

Inclusion Criteria3

• American Society of Anesthesiologists (ASA) Class I-III
Patients aged 18 and over
Those who provided written informed consent at the preoperative anesthesia clinic and allowed telephone follow-up on days 2/8.

Exclusion Criteria3

• ASA Class IV and V
Patients under 18 years of age
Treatment of severe sleep disorders: Those with severe OSA confirmed by polysomnography and using active CPAP therapy. • Significant cognitive impairment, delirium, active psychotic disorder that prevents reliable completion of scales. • Regular use of hypnotics/benzodiazepines, sedatives/antipsychotics, or chronic opioids (≥3 days/week in the last month), alcohol or substance abuse. • Perioperative complications: Major complications during surgery, unplanned need for intensive care, or reoperation within the first 24 hours. • Pregnancy or breastfeeding. • Severe systemic disease, unstable cardiopulmonary status.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.